HU for acute treatment of sickle VOC?
- PMID: 23043024
- DOI: 10.1182/blood-2012-08-447102
HU for acute treatment of sickle VOC?
Abstract
In this issue of Blood, Almeida et al report immediate benefits of hydroxyurea (HU) acute administration in diminishing vaso-occlusive processes in sickle cell disease (SCD) mice.(1)
Comment on
-
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.Blood. 2012 Oct 4;120(14):2879-88. doi: 10.1182/blood-2012-02-409524. Epub 2012 Jul 25. Blood. 2012. PMID: 22833547 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

